Replies to post #239976 on Biotech Values

[DewDiligence]

Other nations don’t appear to have the same safety concern that the FDA does about JAK inhibitors.

[DewDiligence]

EU approves PFE’s Cibinqo (abrocitinib) for atopic dermatitis:

https://finance.yahoo.com/news/european-commission-approves-pfizer-cibinqo-142700528.html

Cibinqo figures to be a very big-selling drug if it can gain approval from the FDA; it is under FDA review for AD now (#msg-165038886).

Please see #msg-166380532 for background.